CA2328062A1 - Secreted proteins and polynucleotides encoding them - Google Patents
Secreted proteins and polynucleotides encoding them Download PDFInfo
- Publication number
- CA2328062A1 CA2328062A1 CA002328062A CA2328062A CA2328062A1 CA 2328062 A1 CA2328062 A1 CA 2328062A1 CA 002328062 A CA002328062 A CA 002328062A CA 2328062 A CA2328062 A CA 2328062A CA 2328062 A1 CA2328062 A1 CA 2328062A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- nucleotide sequence
- nucleotide
- amino acid
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Pregnancy & Childbirth (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (27)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8547298P | 1998-05-14 | 1998-05-14 | |
US60/085,472 | 1998-05-14 | ||
US9682498P | 1998-08-17 | 1998-08-17 | |
US60/096,824 | 1998-08-17 | ||
US9984398P | 1998-09-11 | 1998-09-11 | |
US9995098P | 1998-09-11 | 1998-09-11 | |
US60/099,843 | 1998-09-11 | ||
US60/099,950 | 1998-09-11 | ||
US10042498P | 1998-09-15 | 1998-09-15 | |
US60/100,424 | 1998-09-15 | ||
US10232998P | 1998-09-29 | 1998-09-29 | |
US60/102,329 | 1998-09-29 | ||
US10361598P | 1998-10-09 | 1998-10-09 | |
US60/103,615 | 1998-10-09 | ||
US11179998P | 1998-12-11 | 1998-12-11 | |
US60/111,799 | 1998-12-11 | ||
US11215998P | 1998-12-14 | 1998-12-14 | |
US60/112,159 | 1998-12-14 | ||
US11441598P | 1998-12-31 | 1998-12-31 | |
US60/114,415 | 1998-12-31 | ||
US24805999A | 1999-02-10 | 1999-02-10 | |
US09/248,059 | 1999-02-10 | ||
US28715099A | 1999-04-06 | 1999-04-06 | |
US09/287,150 | 1999-04-06 | ||
US09/311,021 US6706869B1 (en) | 1998-02-11 | 1999-05-13 | Map kinase phosphatases and polynucleotides encoding them |
US09/311,021 | 1999-05-13 | ||
PCT/US1999/010843 WO1999058642A2 (en) | 1998-05-14 | 1999-05-14 | Secreted proteins and polynucleotides encoding them |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2328062A1 true CA2328062A1 (en) | 1999-11-18 |
Family
ID=27584491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002328062A Abandoned CA2328062A1 (en) | 1998-05-14 | 1999-05-14 | Secreted proteins and polynucleotides encoding them |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1080180A2 (ja) |
JP (1) | JP2003530296A (ja) |
CA (1) | CA2328062A1 (ja) |
WO (1) | WO1999058642A2 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083700A (en) | 1998-06-26 | 2000-07-04 | Incyte Pharmaceuticals, Inc. | Human goose-type lysozyme |
US6469141B1 (en) | 1998-10-09 | 2002-10-22 | Medical College Of Georgia Research Institute Inc. | D1-like dopamine receptor activity modifying protein |
US6960433B1 (en) | 1998-10-19 | 2005-11-01 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
WO2000053636A2 (en) * | 1999-03-08 | 2000-09-14 | Ceptyr, Inc. | Dsp-1 dual-specificity map kinase phosphatase |
WO2000060078A2 (en) * | 1999-04-01 | 2000-10-12 | Cold Spring Harbor Laboratory | Latheo encodes a subunit of the origin of recognition complex |
DE60043242D1 (de) * | 1999-08-03 | 2009-12-10 | Genentech Inc | Ausgeschiedene und transmembrane Polypeptide und dafür kodierende Nukleinsäure |
WO2001014552A1 (fr) * | 1999-08-19 | 2001-03-01 | Kurokawa, Kiyoshi | Proteine meg-1 |
AU2084601A (en) * | 1999-12-10 | 2001-06-18 | Biogen, Inc. | Novel polypeptides and polynucleotides encoding same |
CA2399569A1 (en) * | 2001-09-25 | 2003-03-25 | Yusuke Nakamura | Diagnostic markers and drug targets for treatment of cancer |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
CN105601741A (zh) | 2011-04-15 | 2016-05-25 | 卡姆普根有限公司 | 多肽和多核苷酸及其用于治疗免疫相关失调和癌症的用途 |
-
1999
- 1999-05-14 CA CA002328062A patent/CA2328062A1/en not_active Abandoned
- 1999-05-14 WO PCT/US1999/010843 patent/WO1999058642A2/en not_active Application Discontinuation
- 1999-05-14 JP JP2000548435A patent/JP2003530296A/ja not_active Withdrawn
- 1999-05-14 EP EP99924280A patent/EP1080180A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1999058642A3 (en) | 2000-03-02 |
JP2003530296A (ja) | 2003-10-14 |
EP1080180A2 (en) | 2001-03-07 |
WO1999058642A2 (en) | 1999-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6380362B1 (en) | Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use | |
CA2339047A1 (en) | Secreted proteins and polynucleotides encoding them | |
Sprecher et al. | Cloning and characterization of a novel class I cytokine receptor | |
Oda et al. | Identification and Cloning of the Human Homolog (JAG1) of the RatJagged1Gene from the Alagille Syndrome Critical Region at 20p12 | |
US20030092175A1 (en) | Human proteins having transmembrane domains and dnas encoding these proteins | |
CA2226087A1 (en) | Nucleotide and protein sequences of vertebrate delta genes and methods based thereon | |
CA2328062A1 (en) | Secreted proteins and polynucleotides encoding them | |
CA2338186A1 (en) | Tumor necrosis factor-gamma | |
CA2327457A1 (en) | Secreted proteins and polynucleotides encoding them | |
US6242419B1 (en) | Compositions isolated from stromal cells and methods for their use | |
US20010039335A1 (en) | Secreted proteins and polynucleotides encoding them | |
WO1999054447A2 (de) | Menschliche nukleinsäuresequenzen aus blasentumorgewebe | |
CA2382622A1 (en) | Polycyclic aromatic hydrocarbon induced molecules | |
AU784881B2 (en) | Human transporter proteins and polynucleotides encoding the same | |
EP1012286B1 (en) | Allelic variant of human stat3 | |
US6590089B1 (en) | RVP-1 variant differentially expressed in Crohn's disease | |
CA2378485A1 (en) | Proliferation differentiation factor | |
US6960649B2 (en) | Human potassium channel polynucleotides and polypeptides and uses thereof | |
Kim et al. | Cloning of novel trinucleotide-repeat (CAG) containing genes in mouse brain | |
EP1297011B1 (en) | Diagnostic uses of the t-cell protein tzon7, and of the peptides and antibodies derived therefrom | |
Veske et al. | Organization of the canine gene encoding the E isoform of retinal guanylate cyclase (cGC-E) and exclusion of its involvement in the inherited retinal dystrophy of the Swedish Briard and Briard–Beagle dogs | |
US20070037161A1 (en) | Motoneuronotrophic factor gene sequences | |
US20010010926A1 (en) | New immunoregulatory protein lst-1 | |
JPH06315382A (ja) | Tie−2受容体をコードするdna及びtie−2受容体 | |
JPH0870870A (ja) | hTFIIIA遺伝子 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |